Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM
Abstract Sulfonylureas are anti-diabetic medications that act by inhibiting pancreatic KATP channels composed of SUR1 and Kir6.2. The mechanism by which these drugs interact with